arXiv ScienceSearch

arXiv subjects

Jesse Phitidis

Publications and source records attributed to Jesse Phitidis.

2 recordsLinked to original sources

Comparative evaluation of training strategies using partially labelled datasets for segmentation of white matter hyperintensities and stroke lesions in FLAIR MRI

White matter hyperintensities (WMH) and ischaemic stroke lesions (ISL) are key imaging biomarkers of cerebral small vessel disease (SVD) detectable on magnetic resonance imaging (MRI). The development of robust deep learning models to automatically segment and differentiate these pathologies remains challenging. Specifically, WMH and ISL frequently co-occur within the same subject and present as visually confounding hyperintensities on fluid-attenuated inversion recovery (FLAIR) sequences, complicating their accurate delineation. To address the scarcity of fully annotated cohorts, we systematically evaluated six accessible strategies for training a joint WMH and ISL segmentation model using partially labelled data. We aggregated privately held and publicly available datasets to curate a large-scale cohort of 2,052 MRI volumes, of which 1341 and 1152 volumes contained ground truth annotations for WMH and ISL, respectively. Our analysis indicates that multiple strategies effectively leverage partially labelled data to enhance overall model performance, with pseudolabelling emerging as the most effective approach. This model exhibited a consistent WMH segmentation policy and successfully detected the majority of FLAIR-positive ISL. These findings demonstrate the viability of using partially labelled data to develop reliable automated segmentation tools, which can support ongoing SVD monitoring and high-throughput biomarker extraction for large-scale clinical research.

cs.CV

Automated neuroradiological support systems for multiple cerebrovascular disease markers -- A systematic review and meta-analysis

Cerebrovascular diseases (CVD) can lead to stroke and dementia. Stroke is the second leading cause of death world wide and dementia incidence is increasing by the year. There are several markers of CVD that are visible on brain imaging, including: white matter hyperintensities (WMH), acute and chronic ischaemic stroke lesions (ISL), lacunes, enlarged perivascular spaces (PVS), acute and chronic haemorrhagic lesions, and cerebral microbleeds (CMB). Brain atrophy also occurs in CVD. These markers are important for patient management and intervention, since they indicate elevated risk of future stroke and dementia. We systematically reviewed automated systems designed to support radiologists reporting on these CVD imaging findings. We considered commercially available software and research publications which identify at least two CVD markers. In total, we included 29 commercial products and 13 research publications. Two distinct types of commercial support system were available: those which identify acute stroke lesions (haemorrhagic and ischaemic) from computed tomography (CT) scans, mainly for the purpose of patient triage; and those which measure WMH and atrophy regionally and longitudinally. In research, WMH and ISL were the markers most frequently analysed together, from magnetic resonance imaging (MRI) scans; lacunes and PVS were each targeted only twice and CMB only once. For stroke, commercially available systems largely support the emergency setting, whilst research systems consider also follow-up and routine scans. The systems to quantify WMH and atrophy are focused on neurodegenerative disease support, where these CVD markers are also of significance. There are currently no openly validated systems, commercially, or in research, performing a comprehensive joint analysis of all CVD markers (WMH, ISL, lacunes, PVS, haemorrhagic lesions, CMB, and atrophy).

physics.med-ph